Intravenous Vitamin C Supplementation on the Quality of Sleep, Itching,Restlessleg Syndrome in Patients Undergoing Hemodialysis

Not Applicable

• Conditions: Condition 1: Chronic kidney disease. Condition 2: restless leg syndrome. Condition 3: Sleep Quality.; Chronic kidney disease (CKD); Restless legs syndrome; Insomnia, unspecified; G25.81; G47.00

• Registration Number: IRCT20141208020249N4
• Lead Sponsor: Sanandaj University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 14 January 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Patients with low sleep quality (score less than 5 based on global scores)
Kidney failure, which has been dialyzed for at least 6 months
signing Informed consent
Kidney failure, which is dialyzed at least 3 times a week.
Insomnia and or itching and or restless leg syndrome
18 to 70 years old

Exclusion Criteria

Dissatisfaction with the company in the study
Failure to cooperate in completing the Petersburg quality of sleep questionnaire
People who have recived vitamins C, E, or multi-vitamins containing vitamin C, E or fish oil during the two months before the study
A history of mental illness, severe heart and respiratory disease, or a history of infectious disease three months before the study began.
Taking immunosuppressive drugs in the last two months.
Patients who have undergone kidney transplantation and returned to hemodialysis.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Itching. Timepoint: At the start of the study and after 8 weeks receiving the drug. Method of measurement: Level of itching according to VAS criteria.;Restless leg syndrome. Timepoint: At the start of the study and after 8 weeks receiving the drug. Method of measurement: history taking and Clinical Evaluation.;Sleep Quality. Timepoint: At the start of the study and after 8 weeks receiving the drug. Method of measurement: Pittsburgh Sleep Quality Standards Questionnaire (PSQI).